The ROE as of December 2024 (TTM) for Celcuity Inc. (CELC) is -62.66%

According to Celcuity Inc.’s latest financial reports and current stock price. The company's current ROE is -62.66%. This represents a change of 298.02% compared to the average of -15.74% of the last 4 quarters.

Celcuity Inc. (CELC) Historical ROE (quarterly & annually)

How has CELC ROE performed in the past?

The mean historical ROE of Celcuity Inc. over the last ten years is -43.17%. The current -62.66% ROE has changed 45.13% with respect to the historical average. Over the past ten years (40 quarters), CELC's ROE was at its highest in in the June 2001 quarter at 0%. The ROE was at its lowest in in the June 2021 quarter at -51.91%.

Celcuity Inc. (CELC) ROE by Quarter and Year

Discovering the peaks and valleys of Celcuity Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Celcuity Inc. (CELC) Average ROE

How has CELC ROE performed in the past?

The current ROE of Celcuity Inc. (CELC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Celcuity Inc. (CELC) ROE vs. Peers

How is CELC’s ROE compared to its peers?

Celcuity Inc.’s ROE is greater than Werewolf Therapeutics, Inc. (-58.83%), greater than Edgewise Therapeutics, Inc. (-26.83%), greater than Decibel Therapeutics, Inc. (-56.38%), greater than C4 Therapeutics, Inc. (-42.45%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), greater than Adagene Inc. (-50.10%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.95%), greater than AnaptysBio, Inc. (-287.94%), greater than Mineralys Therapeutics, Inc. (-55.92%), greater than Molecular Partners AG (-39.16%), greater than MediciNova, Inc. (-20.70%), less than Champions Oncology, Inc. (66.22%), greater than Cyteir Therapeutics, Inc. (-9.44%), greater than Ikena Oncology, Inc. (-39.59%), greater than Rezolute, Inc. (-69.83%), greater than Aerovate Therapeutics, Inc. (-90.19%), greater than AN2 Therapeutics, Inc. (-57.63%),

Build a custom stock screener for Celcuity Inc. (CELC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celcuity Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Celcuity Inc. (CELC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Celcuity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.